S100B and Parkinson disease: Recent studies showed S100B and HMGB1 were increased in PD and ablation protected against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced toxicity through the RAGE signal pathway (Sathe et al., 2012; Santoro et al., 2016).